中文 | English
Return
Total: 3 , 1/1
Show Home Prev Next End page: GO
Author:(Mu Sheng ZENG)

1.ZNF488 Enhances the Invasion and Tumorigenesis in Nasopharyngeal Carcinoma Via the Wnt Signaling Pathway Involving Epithelial Mesenchymal Transition.

Dan ZONG ; Li YIN ; Qian ZHONG ; Wen Jie GUO ; Jian Hua XU ; Ning JIANG ; Zhi Rui LIN ; Man Zhi LI ; Ping HAN ; Lin XU ; Xia HE ; Mu Sheng ZENG

Cancer Research and Treatment 2016;48(1):334-344

2.Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.

Ning XUE ; Jian Hua LIN ; Shan XING ; Dan LIU ; Shi Bing LI ; Yan Zhen LAI ; Xue Ping WANG ; Min Jie MAO ; Qian ZHONG ; Mu Sheng ZENG ; Wan Li LIU

Cancer Research and Treatment 2019;51(1):378-390

3.Combination of Tumor Volume and Epstein-Barr Virus DNA Improved Prognostic Stratification of Stage II Nasopharyngeal Carcinoma in the Intensity Modulated Radiotherapy Era: A Large-Scale Cohort Study.

Qiu Yan CHEN ; Shao Yan GUO ; Lin Quan TANG ; Tong Yu LU ; Bo Lin CHEN ; Qi Yu ZHONG ; Meng Sha ZOU ; Qing Nan TANG ; Wen Hui CHEN ; Shan Shan GUO ; Li Ting LIU ; Yang LI ; Ling GUO ; Hao Yuan MO ; Rui SUN ; Dong Hua LUO ; Chong ZHAO ; Ka Jia CAO ; Chao Nan QIAN ; Xiang GUO ; Mu Sheng ZENG ; Hai Qiang MAI

Cancer Research and Treatment 2018;50(3):861-871

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 3 , 1/1 Show Home Prev Next End page: GO